Strategies to safely rule out pulmonary embolism in COVID-19 outpatients: a multicenter retrospective study

Objectives The objective was to define a safe strategy to exclude pulmonary embolism (PE) in COVID-19 outpatients, without performing CT pulmonary angiogram (CTPA). Methods COVID-19 outpatients from 15 university hospitals who underwent a CTPA were retrospectively evaluated. D-Dimers, variables of t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European radiology 2023-08, Vol.33 (8), p.5540-5548
Hauptverfasser: Chassagnon, Guillaume, El Hajjam, Mostafa, Boussouar, Samia, Revel, Marie-Pierre, Khoury, Ralph, Ghaye, Benoît, Bommart, Sebastien, Lederlin, Mathieu, Tran Ba, Stephane, De Margerie-Mellon, Constance, Fournier, Laure, Cassagnes, Lucie, Ohana, Mickael, Jalaber, Carole, Dournes, Gael, Cazeneuve, Nicolas, Ferretti, Gilbert, Talabard, Pauline, Donciu, Victoria, Canniff, Emma, Debray, Marie-Pierre, Crutzen, Bernard, Charriot, Jeremy, Rabeau, Valentin, Khafagy, Philippe, Chocron, Richard, Leonard Lorant, Ian, Metairy, Loic, Ruez-Lantuejoul, Lea, Beaune, Sébastien, Hausfater, Pierre, Truchot, Jennifer, Khalil, Antoine, Penaloza, Andrea, Affole, Thibaut, Brillet, Pierre-Yves, Roy, Catherine, Pucheux, Julien, Zbili, Jordan, Sanchez, Olivier, Porcher, Raphael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives The objective was to define a safe strategy to exclude pulmonary embolism (PE) in COVID-19 outpatients, without performing CT pulmonary angiogram (CTPA). Methods COVID-19 outpatients from 15 university hospitals who underwent a CTPA were retrospectively evaluated. D-Dimers, variables of the revised Geneva and Wells scores, as well as laboratory findings and clinical characteristics related to COVID-19 pneumonia, were collected. CTPA reports were reviewed for the presence of PE and the extent of COVID-19 disease. PE rule-out strategies were based solely on D-Dimer tests using different thresholds, the revised Geneva and Wells scores, and a COVID-19 PE prediction model built on our dataset were compared. The area under the receiver operating characteristics curve (AUC), failure rate, and efficiency were calculated. Results In total, 1369 patients were included of whom 124 were PE positive (9.1%). Failure rate and efficiency of D-Dimer > 500 µg/l were 0.9% (95%CI, 0.2–4.8%) and 10.1% (8.5–11.9%), respectively, increasing to 1.0% (0.2–5.3%) and 16.4% (14.4–18.7%), respectively, for an age-adjusted D-Dimer level. D-dimer > 1000 µg/l led to an unacceptable failure rate to 8.1% (4.4–14.5%). The best performances of the revised Geneva and Wells scores were obtained using the age-adjusted D-Dimer level. They had the same failure rate of 1.0% (0.2–5.3%) for efficiency of 16.8% (14.7–19.1%), and 16.9% (14.8–19.2%) respectively. The developed COVID-19 PE prediction model had an AUC of 0.609 (0.594–0.623) with an efficiency of 20.5% (18.4–22.8%) when its failure was set to 0.8%. Conclusions The strategy to safely exclude PE in COVID-19 outpatients should not differ from that used in non-COVID-19 patients. The added value of the COVID-19 PE prediction model is minor. Key Points • D-dimer level remains the most important predictor of pulmonary embolism in COVID-19 patients. • The AUCs of the revised Geneva and Wells scores using an age-adjusted D-dimer threshold were 0.587 (95%CI, 0.572 to 0.603) and 0.588 (95%CI, 0.572 to 0.603). • The AUC of COVID-19-specific strategy to rule out pulmonary embolism ranged from 0.513 (95%CI: 0.503 to 0.522) to 0.609 (95%CI: 0.594 to 0.623).
ISSN:1432-1084
0938-7994
1432-1084
DOI:10.1007/s00330-023-09475-6